Tsumura & Co. | Ownership
Companies that own Tsumura & Co.
Invesco Asset Management (Japan) Ltd.
6,134,600
7.99%
-270,000
4.75%
03/15/2018
Sompo Japan Nipponkoa Asset Management Co., Ltd.
4,931,200
6.42%
1,158,500
6.1%
02/28/2018
Baillie Gifford & Co.
1,902,100
2.48%
9,900
0.04%
04/30/2018
Templeton Investment Counsel LLC
1,780,573
2.31%
323,500
0.28%
03/31/2018
Nikko Asset Management Co., Ltd.
1,616,800
2.11%
-528,100
0.03%
11/15/2017
The Vanguard Group, Inc.
1,581,779
2.06%
-100
0%
07/31/2018
Nomura Asset Management Co., Ltd.
1,353,498
1.76%
32,486
0.03%
07/31/2018
JPMorgan Asset Management (Japan) Ltd.
1,281,200
1.67%
351,600
0.32%
06/30/2018
Norges Bank Investment Management
1,251,600
1.63%
178,606
0.01%
12/31/2017
APG Asset Management NV
823,057
1.07%
231,616
0.02%
03/31/2018
| Address |
2-17-11 Akasaka
Tokyo Tokyo 107
Japan
|
|
Employees
|
- |
| Website |
http://www.tsumura.co.jp |
| Updated |
07/08/2019 |
| Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. It manufactures and sells Kampo medicine, a traditional form of medicine in Japan. The company is also involved in the procurement, sorting, production, processing, and storage of botanical raw materials; production and sale of Kampo extract intermediates; and provision of logistics, storage, distribution, and materials handling services. |
